Mechanisms of biological effects of ionic liquids: from single cells to multicellular organisms

KS Egorova, AV Kibardin, AV Posvyatenko… - Chemical …, 2024 - ACS Publications
The review presents a detailed discussion of the evolving field studying interactions
between ionic liquids (ILs) and biological systems. Originating from molten salt electrolytes …

Organic cation transporters in health and disease

H Koepsell - Pharmacological reviews, 2020 - Elsevier
The organic cation transporters (OCTs) OCT1, OCT2, OCT3, novel OCT (OCTN) 1, OCTN2,
multidrug and toxin exclusion (MATE) 1, and MATE kidney-specific 2 are polyspecific …

Toward the proactive design of sustainable chemicals: Ionic liquids as a prime example

S Beil, M Markiewicz, CS Pereira, P Stepnowski… - Chemical …, 2021 - ACS Publications
The tailorable and often unique properties of ionic liquids (ILs) drive their implementation
into a broad variety of seminal technologies. The modular design of ILs allows in this context …

[HTML][HTML] Renal drug transporters and their significance in drug–drug interactions

J Yin, J Wang - Acta Pharmaceutica Sinica B, 2016 - Elsevier
The kidney is a vital organ for the elimination of therapeutic drugs and their metabolites.
Renal drug transporters, which are primarily located in the renal proximal tubules, play an …

Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1

S Omote, N Matsuoka, H Arakawa, T Nakanishi… - Scientific reports, 2018 - nature.com
Creatinine is actively secreted across tubular epithelial cells via organic cation transporter 2
(OCT2) and multidrug and toxin extrusion 1 (MATE1). We previously showed that the …

Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin and atorvastatin to predict drug-drug interactions (DDIs)

P Duan, P Zhao, L Zhang - European journal of drug metabolism and …, 2017 - Springer
Background The disposition of statins varies and involves both metabolizing enzymes and
transporters, making predictions of statin drug-drug interactions (DDIs) challenging …

The role of drug transporters in the kidney: lessons from tenofovir

DM Moss, M Neary, A Owen - Frontiers in pharmacology, 2014 - frontiersin.org
Tenofovir disoproxil fumarate, the prodrug of nucleotide reverse transcriptase inhibitor
tenofovir, shows high efficacy and relatively low toxicity in HIV patients. However, long-term …

Investigation of endogenous compounds applicable to drug–drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans

Y Tsuruya, K Kato, Y Sano, Y Imamura, K Maeda… - Drug Metabolism and …, 2016 - Elsevier
This study was a comprehensive analysis of metabolites in plasma and urine specimens
from subjects who received probenecid, a potent inhibitor of renal organic anion transporters …

The complexities of interpreting reversible elevated serum creatinine levels in drug development: does a correlation with inhibition of renal transporters exist?

X Chu, K Bleasby, GH Chan, I Nunes… - Drug Metabolism and …, 2016 - Elsevier
In humans, creatinine is formed by a multistep process in liver and muscle and eliminated
via the kidney by a combination of glomerular filtration and active transport. Based on …

Discovery of competitive and noncompetitive ligands of the organic cation transporter 1 (OCT1; SLC22A1)

EC Chen, N Khuri, X Liang, A Stecula… - Journal of medicinal …, 2017 - ACS Publications
Organic cation transporter 1 (OCT1) plays a critical role in the hepatocellular uptake of
structurally diverse endogenous compounds and xenobiotics. Here we identified competitive …